chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a registered nurse concerning a physician who in 2001 was vaccinated with VARIVAX (Merck) (Lot number was not reported). the nurse reported that in 2001 the physician was a part of a study of 15 healthy controls administered VARIVAX (Merck). Subsequently the patient experienced lymphoma after vaccination. It was unspecified if the patient sought medical attention. At the time of the report, the outcome of the event was unknown. Upon internal review, lymphoma was considered to be an other important medical event. This is one of several reports received from the same source. Additional information has been requested.
Immediately after administering the vaccine the patient experienced an injection site reaction that caused swelling at the injection site and redness of the skin.  After 10 minutes of waiting in the vaccination room, the patient's swelling went down and the redness went away.
This spontaneous report was received from a Nurse Practitioner regarding an unspecified number of patients of unknown demographics. There was no information about concurrent condition and historical medication. On 15-AAUG-2106, 16-AUG-2016, 17-AUG-2016, 18-AUG-2016 and 19-AUG-2016, the patients were vaccinated with improperly stored (wistar ra 27-3) M-M-R II (incorrect product storage). No adverse event was reported. The outcome of the event was unknown. No PQC (product quality complaint) was developed. This is one of several reports received from the same reporter. Additional information has been requested.
Bloody and mucousy stools started right after the 1st dose, the doctor assured that it?s not vaccine related, and put me on a dairy/soy free diet (I?m exclusively breastfeeding).  The diet didn?t help, we?re still having bloody stools which worsen after each vaccine dose.  My daughter got her 3rd dose today and had an upset tummy again a few hours later + green stool with bloody mucous.
Constant chest pain going on 2 weeks now. Has not resolved. Visit with my PCP diagnosed with esophagitis. Started on pantoprazole 40mg bid with no improvement after 13 days. Now I need to see specialists.
Pain in the arm. While sitting watching TV the pain started moving around to different joints. Out of nowhere his blood pressure went to 178/127.  Took 2 aspirins.  and one of his prescriptions.  It started going down. It took a day to normalize.  Still having the joint pain. Went to the doctor they are running test.
14-15 varicella sites (not wild type) no fever, no itching sites red, pinpoint with fluid.  Also has bilateral ear infection diagnosed on 07/18/2006 by doctor.
pt brought to hospital via EMS due to generalized weakness that has increased over past 3 days; fell this morning at home due to weakness; fever; placed on O2 via NC; positive for COVID; O2 requirements increased; pt taken for a CT Scan and while in the room pt coded; CPR unsuccessful; pt died in the hospital
12/15/22  I had bad head cold symptoms. I had a headache, sinus stuffiness, high fever and coughing. I was taking Claritin D, cough syrup, cough drops, Advil, Nyquil, and sinus medication. I took an at home COVID test which was positive. This went on for a week or week and a half.  I have been tired and have trouble getting my energy, still.
aches; 104 degree F fever which has now degraded to a low-grade fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (aches) and PYREXIA (104 degree F fever which has now degraded to a low-grade fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (aches) and PYREXIA (104 degree F fever which has now degraded to a low-grade fever). At the time of the report, PAIN (aches) and PYREXIA (104 degree F fever which has now degraded to a low-grade fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 104 (Inconclusive) 104 degree F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medications reported by investigator  No treatment medications provided by the reporter.
I believe I am suffering from worsening side effects after receiving the shingles vaccine on 7/12/2010. I have referred me to a dermatologist whose name I cannot remember. I recall my children coming down with the chicken pox; however, I cannot recall ever having the chicken pox. I have been suffering with a worsening severe itching of my scalp (like it is on fire) ever since I received the vaccine. My daughter has said that the dermatomes affected were only in the C2 area but now have started occurring in the V1 area as well. My daughter is writing this information for me.  I have an appointment again with my dermatologist in a week. I cannot stand this itching any longer. The topical steroids I have been prescribed are unable to address the likelihood of what seems to be a viral response to the vaccination. I hope you can send this information to the appropriate person to help me. My daughter has contacted facility also, my endocrinologist and the pharmacist. Please, please help me. Thank you.
Site: Itching at Injection Site-Mild, Systemic: Fainting / Unresponsive-Severe, Systemic: patient has severe anxiety -Mild, Systemic: Shakiness-Mild, Additional Details: patient suffers from severe anxiety. Patient reported it has happened before with other vaccinations
The first and second dose, I had full body rash, body aches, fever, and chills.  The booster shot (3rd dose), I had chest pain that started the following morning and it progressively got worse.  I eventually throbbing pain on my left chest and my left side of the body couldn't move the way I wanted it to; it was very weak.  I went to the emergency room, and was admitted into the hospital.
Caller tested positive for COVID; This is a spontaneous report from a contactable pharmacist. A female patient of unspecified received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiration date were not reported) via unspecified route on 12Mar2021 at single dose for covid-19 immunisation. The patient was allergic to penicillin, aspartame - caused throat swelling, bee stings and was lactose intolerant and wanted to know if vaccine contains any of these allergens patient has. The patient's concomitant medications were not reported. On 17Mar2021, the patient tested positive for COVID. She had been informed that there must be a 3 month wait in between getting vaccine after being positive for COVID. The outcome of the events was unknown.  No follow-up attempts are Possible. Information on Lot/batch number cannot be obtained.
My symptoms were extreme weakness or fatigue, sneezing, sore throat, headaches...I went to facility and was diagnosed with a mild case of the flu.  The doctor said he was unable to tell me what type of flu I had.  I still am currently being medicated and I have not yet recovered.
Patient is fine after Fluvirin shot. Patient reacts to Pneumovax (2nd shot). Patient complained of SOB 911 was called immediately. Pt also complained of terrible back. Paramedic determined pt's signs and symptoms are not due to an allergic to the vaccines.
Approx 20 sec after receiving Gardasil vacc patient stated felt funny, slumped over and passed out.
Administration of an expired Moderna COVID Vaccine as a second booster dose; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administration of an expired Moderna COVID Vaccine as a second booster dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045J21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension since 15-Mar-2021, Hyperlipidemia since 15-Mar-2021, Diabetes since 15-Mar-2021 and Urinary retention since 15-Mar-2021.   On 27-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-May-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administration of an expired Moderna COVID Vaccine as a second booster dose). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administration of an expired Moderna COVID Vaccine as a second booster dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant were reported. It was reported that patient did not experience any other adverse event. No treatment were reported.
A non-serious spontaneous report of given expired FLUMIST was received from a health professional concerning a male patient. Neither relevant medical history nor concomitant medications have been reported for this patient. The product expired on 11-Dec-2011. On 22-Dec-2011, the patient received expired FLUMIST. There was no adverse event associated with this medication error, therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved.
Loss of taste and dry mouth since august 8th 2018. Tried compound mouth wash and swallow (tetra/nyst/hydroc/ben/lido.1.5G) still no taste bud no other symptoms at all. Other wise healthy.
The pt developed regression, high pitch screaming, eye rolling, head banging 3 months after MMR vaccination. Diagnosed with autism.
The first dose administered was Moderna, and given at a different facility 7/25/2022. Administered the second dose 08/29/2022, which was Pfizer. Patient scheduled 10/24/2022 to receive the third dose (Pfizer). We would like to know how to proceed.
Hip pain; body aches; administered x2 vials of liquid Arexvy adjuvant rather then one; administered x2 vials of liquid Arexvy adjuvant rather then one; This non-serious case was reported by a pharmacist via sales rep and described the occurrence of pain in hip in a female patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis.   On 31-OCT-2023, the patient received the 1st dose of Arexvy. On 31-OCT-2023, an unknown time after receiving Arexvy, the patient experienced inappropriate preparation of medication (Verbatim: administered x2 vials of liquid Arexvy adjuvant rather then one) and inappropriate dose of vaccine administered (Verbatim: administered x2 vials of liquid Arexvy adjuvant rather then one). On an unknown date, the patient experienced pain in hip (Verbatim: Hip pain) and general body pain (Verbatim: body aches). The outcome of the pain in hip and general body pain were not resolved and the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   The reporter considered the pain in hip and general body pain to be related to Arexvy.  The company considered the pain in hip and general body pain to be related to Arexvy.   Additional Information: GSK Receipt Date: 03-NOV-2023 This report was submitted via the online direct entry reporting system.  The hip pain and body aches were reported as worsened. The patient was administered with two vials of liquid Arexvy adjuvant rather than x1 lyophilized powder reconstituted with x1 vial adjuvant, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The volume administered was more than 0.5 mL but the exact was unknown.  The reporter of ADE said no other adjuvanted vaccines were given recently.  No additional patient information was known. The reporter would get patient information and details would update when those were received.  The VAERS report might had already been submitted (unsure). This was not related to an existing case. The reporter consented to follow up.
I was moderately fatigued for 48 hours.  Had intermittent mild muscle and joint pains for 48 hours.  Was slightly light headed for 24 hours.
Nausea, severe abdominal cramping, fever 101.3 degrees, headache.  After a 36 hours most have subsided except stomach cramping which continues a reduced level.
Extremity pain, joint pain, and weakness unable to walk. Decreased reflex in legs, ataxic movements. Hospitalized on 8/8/2012 and diagnosed with Guillain Barre Syndrome.
Patient was accidently given Heplisav B vaccine instead of Bexsero Vaccine.
A monovalent vaccine was administered instead of a bivalent booster dose to one patient; No adverse event; This spontaneous case was reported by a physician and describes the occurrence of WRONG PRODUCT ADMINISTERED (A monovalent vaccine was administered instead of a bivalent booster dose to one patient) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (A monovalent vaccine was administered instead of a bivalent booster dose to one patient) and NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (A monovalent vaccine was administered instead of a bivalent booster dose to one patient) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (A monovalent vaccine was administered instead of a bivalent booster dose to one patient).    No concomitant medication information was provided. No treatment medication was provided.   Reporter did not allow further contact
Please see the entry in item for allergies.  The adverse event was mild hemolysis. Symptoms were unexplained back pain approximately two days after the injection; at about 1 week after injection, sharp pain in the area of the spleen along with unexplained fatigue in exercising and my left fingers and toes turned purplish.
MD prescribed vax for self & inadvertently recv peds dose;MD recv adult dose & exp episode of itching skin & diarrhea for 10 days;current condition of the MD is unk;
1/5 - 1/11/22 recent hospitalization for right hip fx; had a positive COVID test on 1/11/22, pt asymptomatic; and was dc'd to a nursing home; 1/15/22 pt readmitted to hosp for acute encephalopathy; UTI discovered; ABX; DNR/DNI; dexamethasone given with O2 supplementation; worsening condition; made comfort measures only and pt passed away in the hospital; DC and med records sent to info@vaers.org
TOOK LAST DOSE ONE DAY LATE; This spontaneous case report (PVX2019-1825) was received from a nurse on 15-Jul-2019. It describes a 28-year-old adult female consumer who "took last dose one day late" (PT: Inappropriate schedule of product administration). The consumer was receiving oral Vivotif capsule (one dose every other day) for typhoid prophylaxis.  Case report: The consumer took the last dose of Vivotif one day late. The doses were taken on 07-Jul-2019, 09-Jul-2019, 11-Jul-2019, and 14-Jul-2019, respectively.  Action taken with Vivotif was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "took last dose one day late" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took last dose one day late" was considered as not applicable.
Suffered from heart attack evening of vaccine.  Passed away.  health care facility should have notified vaers but wanted to make sure they did.
Immediately after administration, patient experienced a local minor itchiness. Patient continues to having minor itchiness and blister locally for three weeks post injection.
Tired, hard to breath, heart raise over normal. Nebulizer treatment, rest and observation for 3 and a half hours until heart came down to normal rate.
TOOK UNREFRIGERATED DOSES; This spontaneous case report (PVX2019-2304) was received from a consumer on 09-Sep-2019. It described a 60-years-old female consumer who "took unrefrigerated doses" (PT: Product storage error), while being on Vivotif for an unknown indication.  Case report: The consumer left Vivotif doses unrefrigerated overnight at 79 to 80-degree Fahrenheit and it were no longer good to use. She took all the doses from 26-Aug-2019 to 01-Sep-2019.  Action taken with Vivotif was not applicable.  The clinical outcome with respect to the event was unknown.  Company's Comment: The causality of the event "took unrefrigerated doses" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took unrefrigerated doses" was considered as not applicable.
late for the second dose/first dose/October 2019; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose in October 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The patient was late for 2nd dose of Shingrix and till the time of reporting, she did not receive it, which led to incomplete course of vaccination. No adverse events was reported. The patient identifier, lot number, expiration date and vaccination date for 1st dose was not provided. The reporter did not consent to follow up.
Reported Shingles one week after receiving Shingrix; This case was reported by a other health professional via call center representative and described the occurrence of shingles in a 52-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   In August 2020, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, 1 week after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were as follows: The age at vaccination was not reported. The healthcare professional reported that one week after the vaccination patient experienced shingles. The consumer reported to the physician on 23rd September 2020, he received the vaccine approximately two weeks ago. The reporter did not consent to follow up.
p/vax pt was found dead by family member;exact time of death has not been established;autopsy to determine COD is being conducted 10/21/99;
Rash about the diameter of a tennis ball at injection site, pain, itching.  Symptoms lasted for two days, and still going at this time.
24hr p/vax had fever, h/a & muscle aches;arm @ inj site was red, hot & swollen;6-8in long by 3 in wide;used ice & Ibuprofen;recovered in 3 days;
Patient presented with complaint of shortness of breath and cough. She was then tested for COVID-19 and found to be positive.  She was seen by both Infectious Disease and pulmonology and placed on Remdesivir and Decadron.  She was also placed on empiric antibiotics.  Her oxygen requirements increased and at 1 point she required 15 L non-rebreather.  She slowly improved and her hospitalization was prolonged due to her significant oxygen requirements.  She was able to be weaned to nasal cannula and a 6 minutes walk study was performed which revealed the patient was stable on 3 L with ambulation. Patient was discharged home with home o2.
Pt recv vax & devel inj site rxn of swelling,warmth & pain. This is 1of 3 pt from this site to exp adverse rxn w/lot #4968253
Patient was being fussier than usual and then I noticed what appeared to be bug bites, similar to mosquito bites, on her thighs.  There were maybe 10 on each leg.  I thought maybe something had bitten her while she was playing on the floor, so I picked her up, changed her, and put pants on her.  Then I noticed more were appearing on her arms, ankles, chin, and around her mouth.  There ended up being maybe 45 marks over her whole body.  They were red, slightly elevated spots.  I called the pediatrician's office, and they denied that it was a result of the vaccinations, but she had not had any new foods, detergents, etc. that could have triggered a reaction like this.  The nurse told me to put Hydrocortisone cream on her, and I did.  They were still visible the next day (03/02/2012), but as of today (03/03/2012), they appear to be gone.
Left thigh with 11 cm area of erythema with 3 cm induration in center: slight echymotic area near injection site.
Wrist pain and  top of hand swelling (on left arm vaccine side).  Confusion as to whether this is a reaction to shot thus prompting cellulitis like symptoms.  Being treated for cellulitis.  Outcome to be determined
L deltoid area with 2" (ping pong ball) erythema & hardness with another 1" surrounding mild erythema.
delayed menstrual cycle; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EP8736) via an unspecified route of administration in the left arm on 23Apr2021 (at the age of 25- years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Concomitant medications included escitalopram oxalate (LEXAPRO) for unknown indication form unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EW0150) via an unspecified route of administration in the left arm on 02Apr2021.Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Apr2021, the patient underwent rapid COVID-19 virus test and the result was found to be negative. On 23Apr2021 the patient experienced delayed menstrual cycle. The clinical outcome of the event delayed menstrual cycle was unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
hands and feet swelling; headache; back starting hurting; This is a spontaneous report from a contactable consumer (patient's spouse)  A 62-years-old male patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 10Mar2021 (Batch/Lot Number: EN6207) as single dose for covid-19 immunisation.  Medical history included prostate cancer, surgery for prostate cancer about 4 months ago, tooth extraction on 09Mar2021. Concomitant medications included paracetamol (TYLENOL) taken for an unspecified indication, diphenhydramine hydrochloride (BENADRYL), amoxicillin. On 12Mar2021 the patient experienced hands and feet swelling, he started getting body aches and a really severe headache. All events were assessed as non -serious.  It was also informed that on 09Mar2021 he was at the dentist for a dental procedure and they give him amoxicillin. By Friday evening his hand was completely swollen, his legs were swollen a little bit and then his back starting hurting, had a headache so is that may be a combination of amoxicillin and the Pfizer shot (as reported). At the time of the reporting the patient was recovering from the events.    No follow-up attempts are possible. No further information is expected.
Patient states injection site became sore, hard and red. Felt feverish for 2 days. Face was red and hot for 24 hours.